Patent · US Active

BCMA chimeric antigen receptors

US10383929B2 · kind B2 · utility

22Cited by
28References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 7, 2015
Grant dateAug 20, 2019
Priority date—
Expiry dateFeb 9, 2036

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.